Improvement of blood glucose self-monitoring in individuals with type 2 diabetes in community pharmacies (edgar)
- At: 2006 FIP Congress in Salvadore (Brazil)
- Type: Poster
- By: SCHULZ, Martin (ABDA, Berlin, Germany)
- Co-author(s): Mueller, Uta (ABDA, BERLIN, Germany)
Haemmerlein, Andrea (ABDA, BERLIN, Germany)
Casper, Annette (Bayer Healthcare, COLOGNE, Germany)
Objective: The ROSSO study has shown that self-monitoring of blood glucose (SMBG) is clearly correlated with improved life expectancy and reduced long-term complications in people with type 2 diabetes. SMBG not only lead to appropriate adjustments in insulin therapy but also enables patients to assess how certain behaviors influence their blood.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.